Please assess the completion status of the following clinical trial:

Trial Title: Fixed Dose Combination Versus Free Combination of Tiotropium and Olodaterol in COPD

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria:~* Male or female patients.~* Patients 40 years of age or older.~* Patients with a smoking history \> 10 pack years.~* Diagnostic of COPD with Post-bronchodilator FEV1 (Forced Expiratory Volume in one second) \>= 30% and \<80% of predicted normal and Post-bronchodilator FEV1/FVC (Forced Vital Capacity) \<70% at screening.~* Symptomatic patients with CAT (COPD Assessment Test TM) score \>= 10 at screening.~* Further inclusion criteria apply.~Exclusion criteria:~* COPD exacerbation or symptoms of lower respiratory tract infection within 6 weeks prior to screening.~* Patients with a current diagnosis of asthma.~* Further exclusion criteria apply.

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- FDC of tiotropium + olodaterol (Type: EXPERIMENTAL): Fixed Dose Combination of tiotropium + olodaterol
- Free combination tiotropium + olodaterol (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).